Neoadjuvant and adjuvant alpha-blockade improves early results of high-energy transurethral microwave thermotherapy for lower urinary tract symptoms of benign prostatic hyperplasia: a randomized, prospective clinical trial - placebo-controlled, double-blind extension of phase III trial

Author： Djavan B.   Shariat S.   Fakhari M.   Ghawidel K.   Seitz C.   Partin A.W.   Roehrborn C.G.   Marberger M.  

Publisher： Elsevier

ISSN： 0090-4295

Source： Urology, Vol.53, Iss.2, 1999-02, pp. : 251-259

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Temporary intraurethral prostatic bridge-catheter compared with neoadjuvant and adjuvant alpha-blockade to improve early results of high-energy transurethral microwave thermotherapy

By Djavan B.   Ghawidel K.   Basharkhah A.   Hruby S.   Bursa B.   Marberger M.  

Urology, Vol. 54, Iss. 1, 1999-07 ,pp. : 73-80

Elsevier

Access to resources Recommend Favorite

Efficacy and safety of once-daily alfuzosin in the treatment of lower urinary tract symptoms and clinical benign prostatic hyperplasia: a randomized, placebo-controlled trial 1

By Roehrborn C.G.   for the ALFUS STUDY GROUP  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 953-959

Elsevier

Access to resources Recommend Favorite

Long-Term Evaluation of Tamsulosin in Benign Prostatic Hyperplasia: Placebo-Controlled, Double-Blind Extension of Phase III Trial - risk factors and concomitance with hypertension

By Lepor H.  

Urology, Vol. 51, Iss. 6, 1998-06 ,pp. : 901-906

Elsevier

Access to resources Recommend Favorite

Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms 1

By Gerber G.S.   Kuznetsov D.   Johnson B.C.   Burstein J.D.  

Urology, Vol. 58, Iss. 6, 2001-12 ,pp. : 960-963

Elsevier

Access to resources Recommend Favorite

Microwave Thermotherapy for Benign Prostatic Hyperplasia with the Dornier Urowave: Results of a Randomized, Double-blind, Multicenter, Sham-controlled Trial - how much change in AUA symptom index and the BPH impact index is perceptible to patients?

By Roehrborn C.G.   Preminger G.   Newhall P.   Denstedt J.   Razvi H.   Chin L.J.   Perlmutter A.   Barzell W.   Whitmore W.   Fritzsch R.   Sanders J.   Sech S.   Womack S.  

Urology, Vol. 51, Iss. 1, 1998-01 ,pp. : 19-28

Elsevier

Access to resources Recommend Favorite